Professor of Biomedical Engineering
My primary responsibilities involve animal surgeries: coronary artery ligation, implant engineered cardiac tissue patch onto heart, skeletal muscle injury and repair, engineered tissue window chamber implantation, and following implantation studies with biochemical and molecular biology analysis.
I am working on human engineered skeletal and cardiac muscle for organ-on-chip studies.
I work on engineering of excitable fibroblasts for treatment of cardiac arrhythmias.
I am the lab manager for the Bursac Lab, and I also assist lab members with molecular biology and cell culture.
I work on in vitro modeling of human skeletal muscle diseases.
I work on engineered cardiac tissues derived from human pluripotent stem cells.
I work on developing more physiologically relevant tissue engineered skeletal muscle to study both healthy and diseased muscle physiology in human and rat cells.
I study the mechanisms of ion channel trafficking in reponse to biomechanical cues.
I work on designing and engineering electrically active primary human cells with customized electrophysiological phenotypes for cardiac repair.
I am interested in the fidelity of the electrical system and the role of fibroblasts in cardiac regeneration.
My current project is focused on generating functional skeletal muscle bundles with cells derived from human pluripotent stem cells for drug development, disease modeling and implantation therapies.
I am studying the regenerative capacity of tissue-engineered skeletal muscle in vitro.
I am studying the potential of cardiac patches derived from human embryonic and induced pluripotent stem cells to repair damaged tissue after myocardial infarction.
I am studying how mechanical forces regulate the recruitment and membrane distribution of ion channels.
I work on human cardiac tissue engineering from pluripotent stem cells, and gene editing.
I study how different cardiac fibroblast phenotypes affect the structure and function of engineered 3D tissues.
I am exploring methods to improve the regenerative capacity of engineered tissues derived from human skeletal muscle cells.
I am interested in developing tissue-engineered skeletal muscle models of congenital human disease to study diseased physiology and test preclinical treatments.
As a Pratt Fellow working under Hung, I am exploring how to optimize the engineering of excitability and pacemaking properties in primary cells.
I’m currently working on macrophage induced human skeletal muscle regeneration and developing an in vitro model for glycogen storage diseases using engineered human muscle.